DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,871 filers reported holding DANAHER CORPORATION in Q3 2021. The put-call ratio across all filers is 1.50 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $1,121,999 | -19.2% | 4,850 | -13.4% | 0.56% | -20.8% |
| Q3 2023 | $1,389,360 | +3.4% | 5,600 | 0.0% | 0.71% | +8.2% |
| Q2 2023 | $1,344,000 | -9.6% | 5,600 | -5.1% | 0.66% | -15.5% |
| Q1 2023 | $1,487,036 | -9.0% | 5,900 | -4.2% | 0.78% | -12.0% |
| Q4 2022 | $1,634,456 | -3.7% | 6,158 | -6.3% | 0.88% | -3.1% |
| Q3 2022 | $1,697,000 | +2.0% | 6,572 | +0.1% | 0.91% | +9.6% |
| Q2 2022 | $1,664,000 | -13.6% | 6,564 | 0.0% | 0.83% | +2.7% |
| Q1 2022 | $1,925,000 | -16.3% | 6,564 | -6.1% | 0.81% | -9.4% |
| Q4 2021 | $2,299,000 | +7.7% | 6,989 | -0.4% | 0.90% | -0.6% |
| Q3 2021 | $2,135,000 | -15.7% | 7,014 | -25.7% | 0.90% | +13.9% |
| Q2 2021 | $2,532,000 | -6.9% | 9,434 | -21.9% | 0.79% | -0.8% |
| Q1 2021 | $2,720,000 | +1.3% | 12,084 | 0.0% | 0.80% | -2.2% |
| Q4 2020 | $2,684,000 | +3.2% | 12,084 | 0.0% | 0.81% | -6.8% |
| Q3 2020 | $2,602,000 | +21.2% | 12,084 | -0.4% | 0.87% | +16.9% |
| Q2 2020 | $2,146,000 | +23.7% | 12,134 | -3.2% | 0.75% | +5.1% |
| Q1 2020 | $1,735,000 | -11.2% | 12,534 | -1.5% | 0.71% | +22.6% |
| Q4 2019 | $1,954,000 | 0.0% | 12,729 | -5.9% | 0.58% | -6.0% |
| Q3 2019 | $1,954,000 | -2.6% | 13,529 | -3.6% | 0.62% | -5.2% |
| Q2 2019 | $2,006,000 | +5.2% | 14,034 | -2.8% | 0.65% | +4.0% |
| Q1 2019 | $1,906,000 | +35.6% | 14,434 | +5.9% | 0.63% | +29.3% |
| Q4 2018 | $1,406,000 | -5.1% | 13,634 | 0.0% | 0.48% | +18.3% |
| Q3 2018 | $1,481,000 | +10.1% | 13,634 | 0.0% | 0.41% | +5.4% |
| Q2 2018 | $1,345,000 | -2.8% | 13,634 | -3.5% | 0.39% | -4.7% |
| Q1 2018 | $1,384,000 | +5.5% | 14,134 | 0.0% | 0.41% | -2.4% |
| Q4 2017 | $1,312,000 | +8.3% | 14,134 | 0.0% | 0.42% | +2.7% |
| Q3 2017 | $1,212,000 | +1.6% | 14,134 | 0.0% | 0.41% | -1.7% |
| Q2 2017 | $1,193,000 | +0.5% | 14,134 | +1.8% | 0.41% | -1.9% |
| Q1 2017 | $1,187,000 | +9.8% | 13,884 | 0.0% | 0.42% | +3.4% |
| Q4 2016 | $1,081,000 | -1.0% | 13,884 | -0.4% | 0.41% | -0.7% |
| Q3 2016 | $1,092,000 | -23.6% | 13,934 | -1.6% | 0.41% | -26.0% |
| Q2 2016 | $1,430,000 | +6.9% | 14,154 | +0.4% | 0.55% | +5.1% |
| Q1 2016 | $1,338,000 | 0.0% | 14,104 | -2.1% | 0.53% | +1.7% |
| Q4 2015 | $1,338,000 | +9.0% | 14,404 | 0.0% | 0.52% | +4.4% |
| Q3 2015 | $1,227,000 | -1.7% | 14,404 | -2.0% | 0.50% | +25.6% |
| Q1 2015 | $1,248,000 | +3.6% | 14,704 | +4.6% | 0.40% | +2.1% |
| Q4 2014 | $1,205,000 | +12.8% | 14,054 | 0.0% | 0.39% | +9.3% |
| Q3 2014 | $1,068,000 | -4.8% | 14,054 | -1.4% | 0.35% | -2.5% |
| Q2 2014 | $1,122,000 | +1.4% | 14,254 | -3.4% | 0.36% | -12.7% |
| Q1 2014 | $1,107,000 | -9.3% | 14,754 | -6.6% | 0.42% | -9.4% |
| Q4 2013 | $1,220,000 | +11.3% | 15,804 | 0.0% | 0.46% | +2.0% |
| Q3 2013 | $1,096,000 | – | 15,804 | – | 0.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |